Navigation Links
Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
Date:11/9/2007

BIRMINGHAM, Ala. and EXTON, Pa., Nov. 9 /PRNewswire-USNewswire/ -- Southern Research Institute and Absorption Systems, LP today announced that they have expanded their joint marketing agreement to allow Absorption Systems to represent Southern Research in European biotechnology and pharmaceutical markets. Ten months ago, the two organizations announced that they had signed a joint marketing agreement to collaborate in marketing contract research services in the areas of toxicology and bioanalytical services to biotechnology and pharmaceutical clients in the U.S.

The agreement expands this partnership so Absorption Systems will provide marketing and sales representation of Southern Research in Europe. Both companies will continue to provide critical preclinical contract research support to the biotechnology and pharmaceutical industries. Financial terms of the agreement were not announced.

"Our international business has expanded dramatically in the past 18 months, so this agreement with Absorption Systems will allow us to enhance our support to those clients, while continuing to expand our geographic reach," said Chaarles G. Fogelgren, director of Business Operations for the Drug Development Division at Southern Research.

"We are excited about expanding our relationship with Southern Research. Adding their capabilities in toxicology, cancer efficacy and anti-infectives to our capabilities in ADME and bioanalysis will provide a better outsourcing solution for our clients," said Patrick Dentinger, president and CEO of Absorption Systems.

The European sales and marketing representation also signals an expansion of Southern Research's dedicated sales force. In the past year, Southern Research has established a U.S.-based geographic sales force (http://www.southernresearch.org/bd-territories.html) and is moving to expand upon this success.

About A
'/>"/>

SOURCE Southern Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
2. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
6. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
7. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
8. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
9. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
10. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
11. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... LONDON , May 27, 2015  The ... provides comprehensive understanding and unprecedented access to the ... worlds leading healthcare companies during 2014. ... gain insight into the partnering activities of the ... view all the partnering and alliances deals announced ...
(Date:5/27/2015)... Research and Markets( http://www.researchandmarkets.com/research/8nqqdw/global_breast ) has ... Cancer Monoclonal Antibodies Market Outlook 2020" report ... to dominate the breast cancer monoclonal antibody segment ... Herceptin has been able to dominate this segment ... cancer cells become recalcitrant and relapsed condition could ...
(Date:5/27/2015)... , May 27, 2015 /CNW/ - CQDM, Brain Canada ... to $8.5M to six (6) multi-disciplinary and multi-provincial research ... within their Focus on Brain strategic initiative. To this ... involved as in-kind contributions. This exciting announcement was made ... for Neuroscience in the presence of Inez Jabalpurwala, President ...
(Date:5/27/2015)... Empowering biomedical researchers with richer, ... Inc. today announced its MR Compatible Small Animal ... Scanner uses silicon photomultiplier detector technology, so it ... from manufacturers like Bruker and Agilent,” said James ... “This enables simultaneous PET and MRI data acquisition ...
Breaking Biology Technology:Companion Diagnostics Deals and Alliances of 2014 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 2Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 4Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 5Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 6Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 7Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 8Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 9Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 10Cubresa Launches Simultaneous PET/MRI Technology 2
... , ROCKVILLE, Md., Nov. 30 Novavax, Inc. (Nasdaq: NVAX ... be presenting at the 21st Annual Health Care Conference 2009 on ... York Palace, New York. Novavax will provide an overview of ... A link to the live audio only presentation can be ...
... , CHANGCHUN, China ... Inc. (OTC Bulletin Board: CYXN; ,China Yongxin,Pharmaceuticals, or ,the ... Northeastern China, today announced it has,completed preparation for distribution ... The Chinese government recently formalized the ...
... ... (Nasdaq and MTA: CTIC) announced today that its new ... stronger anti-tumor potency and activity compared to currently available ... cisplatin-resistance in cancer cell lines. The results were ...
Cached Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
(Date:5/14/2015)... YORK , May 14, 2015 /PRNewswire/ ... in identity verification and online remote proctoring, ... a software-as-a-service (SaaS) company and creator of ... customers of the two companies will benefit ... in Canvas. As a fully ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... that deleting a specific gene in mice prevents them from ... they believe may be replicated in humans. "When fed ... said Prof. James McManaman, Ph.D., lead author of the study ... University of Colorado School of Medicine. "It may be possible ...
... Introductions at a party seemingly go in one ear and ... times during the party, you are more likely to remember his ... the introduction and converted it into a long-term one. The ... complex 2), according to researchers at Baylor College of Medicine ( ...
... As the Colorado River winds through the Colorado Plateau,s soft ... This sediment which once left the river,s waters so ... reddish river" is a vital component to the unique ... Hoover and Glen Canyon dams, which trap the sediment, the ...
Cached Biology News:Researchers discover gene that causes obesity in mice 2Novel storage mechanism allows command, control of memory 2Novel storage mechanism allows command, control of memory 3
... Polymerase is the most thoroughly characterized enzyme ... to its overall utility and efficacy. , ... for PCR applications. , It is ... ,, AmpliTaq DNA Polymerase is a 94 ...
Taq DNA Polymerase (T. aquaticus), 4 x 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying En...
... GCpro Taq DNA Polymerase is a ... advantages for all PCR applications. GCpro Taq ... clone expressed in E. coli, containing the ... The enzyme includes a highly processive 5'-3' ...
Aspergillus (IgG) Ab EIA Sample Size: 100 l...
Biology Products: